BIOMARIN PHARMACEUTICAL INC Increase (Decrease) in Inventories
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Increase (Decrease) in Inventories of -$12.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in inventories for the quarter ending 2026-06-30 was $32.16M, a 33.19% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in inventories for the quarter ending 2026-03-31 was -$44.49M, a 282.82% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in inventories for the quarter ending 2025-12-31 was $18.13M, a 47.09% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in inventories for the quarter ending 2025-09-30 was $26.33M.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in inventories for fiscal 2025 was $116.93M, a 84.05% increase from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in inventories for fiscal 2024 was $63.53M, a 59.55% decline from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in inventories for fiscal 2023 was $157.06M, a 130.07% increase from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC increase (decrease) in inventories for fiscal 2022 was $68.26M, a 94.71% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $32.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$12.33M 10-Q · filed 2026-08-06 | $5.80M derived: sum of 3 quarters · filed 2026-08-06 | $32.13M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$44.49M 10-Q · filed 2026-05-05 | -$26.36M derived: sum of 2 quarters · filed 2026-05-05 | -$23.00K derived: sum of 3 quarters · filed 2026-05-05 | $48.10M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $18.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $44.47M derived: sum of 2 quarters · filed 2026-02-26 | $92.59M derived: sum of 3 quarters · filed 2026-08-06 | $116.93M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $26.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $74.46M derived: sum of 2 quarters · filed 2026-08-06 | $98.80M 10-Q · filed 2025-10-28 | $133.07M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $48.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $72.46M 10-Q · filed 2026-08-06 | $106.73M derived: sum of 3 quarters · filed 2026-08-06 | $88.58M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $24.34M 10-Q · filed 2026-05-05 | $58.61M derived: sum of 2 quarters · filed 2026-05-05 | $40.46M derived: sum of 3 quarters · filed 2026-05-05 | $71.05M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $34.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $16.12M derived: sum of 2 quarters · filed 2026-02-26 | $46.71M derived: sum of 3 quarters · filed 2026-02-26 | $63.53M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$18.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $12.44M derived: sum of 2 quarters · filed 2025-10-28 | $29.26M 10-Q · filed 2025-10-28 | $88.37M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $30.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $47.41M 10-Q · filed 2025-08-05 | $106.52M derived: sum of 3 quarters · filed 2026-02-26 | $147.99M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $16.82M 10-Q · filed 2025-05-02 | $75.93M derived: sum of 2 quarters · filed 2026-02-26 | $117.40M derived: sum of 3 quarters · filed 2026-02-26 | $159.78M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $59.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $100.58M derived: sum of 2 quarters · filed 2026-02-26 | $142.96M derived: sum of 3 quarters · filed 2026-02-26 | $157.06M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $41.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $83.85M derived: sum of 2 quarters · filed 2024-10-31 | $97.95M 10-Q · filed 2024-10-31 | $138.79M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2023-06-30 | $42.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $56.48M 10-Q · filed 2024-08-05 | $97.32M derived: sum of 3 quarters · filed 2025-02-24 | $123.31M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2023-03-31 | $14.10M 10-Q · filed 2024-04-26 | $54.94M derived: sum of 2 quarters · filed 2025-02-24 | $80.93M derived: sum of 3 quarters · filed 2025-02-24 | $83.49M derived: sum of 4 quarters · filed 2025-02-24 | ||||
| 2022-12-31 | $40.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $66.83M derived: sum of 2 quarters · filed 2025-02-24 | $69.39M derived: sum of 3 quarters · filed 2025-02-24 | $68.26M 10-K · filed 2025-02-24 | ||||
| 2022-09-30 | $25.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $28.54M derived: sum of 2 quarters · filed 2023-11-02 | $27.42M 10-Q · filed 2023-11-02 | $43.35M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $1.43M 10-Q · filed 2023-08-02 | $17.37M derived: sum of 3 quarters · filed 2024-02-26 | $42.87M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | -$1.13M 10-Q · filed 2023-04-28 | $14.81M derived: sum of 2 quarters · filed 2024-02-26 | $40.31M derived: sum of 3 quarters · filed 2024-02-26 | $27.51M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | $15.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $41.44M derived: sum of 2 quarters · filed 2024-02-26 | $28.64M derived: sum of 3 quarters · filed 2024-02-26 | $35.06M 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | $25.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $12.70M derived: sum of 2 quarters · filed 2022-10-28 | $19.13M 10-Q · filed 2022-10-28 | $6.97M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | -$12.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$6.38M 10-Q · filed 2022-08-04 | -$18.54M derived: sum of 3 quarters · filed 2023-02-27 | $8.47M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $6.42M 10-Q · filed 2022-04-29 | -$5.73M derived: sum of 2 quarters · filed 2023-02-27 | $21.28M derived: sum of 3 quarters · filed 2023-02-27 | $46.87M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | -$12.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $14.85M derived: sum of 2 quarters · filed 2023-02-27 | $40.45M derived: sum of 3 quarters · filed 2023-02-27 | $61.15M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $27.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $52.60M derived: sum of 2 quarters · filed 2021-10-29 | $73.31M 10-Q · filed 2021-10-29 | $128.29M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $25.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $46.30M 10-Q · filed 2021-07-30 | $101.28M derived: sum of 3 quarters · filed 2022-02-25 | $120.73M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $20.71M 10-Q · filed 2021-04-30 | $75.69M derived: sum of 2 quarters · filed 2022-02-25 | $95.14M derived: sum of 3 quarters · filed 2022-02-25 | $130.00M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $54.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $74.44M derived: sum of 2 quarters · filed 2022-02-25 | $109.29M derived: sum of 3 quarters · filed 2022-02-25 | $107.55M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $19.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $54.31M derived: sum of 2 quarters · filed 2020-11-06 | $52.57M 10-Q · filed 2020-11-06 | $66.09M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $34.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $33.12M 10-Q · filed 2020-08-05 | $46.63M derived: sum of 3 quarters · filed 2021-02-26 | $72.36M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | -$1.74M 10-Q · filed 2020-05-01 | $11.78M derived: sum of 2 quarters · filed 2021-02-26 | $37.51M derived: sum of 3 quarters · filed 2021-02-26 | $32.85M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $13.52M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | $39.24M derived: sum of 2 quarters · filed 2021-02-26 | $34.59M derived: sum of 3 quarters · filed 2021-02-26 | $23.75M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $25.73M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2019-11-04 | $21.07M derived: sum of 2 quarters · filed 2019-11-04 | $10.23M 10-Q/A · filed 2019-11-04 | $26.24M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | -$4.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | -$15.49M 10-Q · filed 2019-08-02 | $512.00K derived: sum of 3 quarters · filed 2020-02-27 | $21.03M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | -$10.84M 10-Q · filed 2019-04-29 | $5.16M derived: sum of 2 quarters · filed 2020-02-27 | $25.68M derived: sum of 3 quarters · filed 2020-02-27 | $63.39M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $36.52M derived: sum of 2 quarters · filed 2020-02-27 | $74.23M derived: sum of 3 quarters · filed 2020-02-27 | $96.89M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $20.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $58.23M derived: sum of 2 quarters · filed 2018-10-26 | $80.89M 10-Q · filed 2018-10-26 | $85.59M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | $37.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $60.37M 10-Q · filed 2018-08-03 | $65.08M derived: sum of 3 quarters · filed 2019-02-28 | $83.28M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | $22.66M 10-Q · filed 2018-04-27 | $27.37M derived: sum of 2 quarters · filed 2019-02-28 | $45.57M derived: sum of 3 quarters · filed 2019-02-28 | $76.89M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $22.91M derived: sum of 2 quarters · filed 2019-02-28 | $54.23M derived: sum of 3 quarters · filed 2019-02-28 | $64.51M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | $18.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $49.52M derived: sum of 2 quarters · filed 2017-10-31 | $59.80M 10-Q · filed 2017-10-31 | $63.32M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $31.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $41.60M 10-Q · filed 2017-08-02 | $42.71M 10-Q · filed 2016-08-08 | $45.12M derived: sum of 3 quarters · filed 2018-02-26 | $63.67M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2016-03-31 | $10.29M 10-Q · filed 2017-05-04 | $11.80M 10-Q · filed 2016-05-02 | $13.80M derived: sum of 2 quarters · filed 2018-02-26 | $32.35M derived: sum of 3 quarters · filed 2018-02-26 | $41.93M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2015-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $22.07M derived: sum of 2 quarters · filed 2018-02-26 | $31.64M derived: sum of 3 quarters · filed 2018-02-26 | $50.99M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $18.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $28.13M derived: sum of 2 quarters · filed 2016-11-03 | $47.47M 10-Q · filed 2016-11-03 | $61.98M 10-Q · filed 2015-11-02 | $28.69M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-06-30 | $9.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $28.92M 10-Q · filed 2016-08-08 | $38.43M 10-Q · filed 2015-08-05 | $10.15M derived: sum of 3 quarters · filed 2017-02-27 | $20.85M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-03-31 | $19.34M 10-Q · filed 2016-05-02 | $23.95M 10-Q · filed 2015-05-05 | $569.00K derived: sum of 2 quarters · filed 2017-02-27 | $11.27M derived: sum of 3 quarters · filed 2017-02-27 | $27.81M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2014-12-31 | -$18.77M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$8.07M derived: sum of 2 quarters · filed 2017-02-27 | $8.47M derived: sum of 3 quarters · filed 2017-02-27 | $22.34M 10-K · filed 2017-02-27 | $36.85M 10-K · filed 2015-03-02 | |||
| 2014-09-30 | $10.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $27.24M derived: sum of 2 quarters · filed 2015-11-02 | $41.11M 10-Q · filed 2015-11-02 | $41.84M 10-Q · filed 2014-10-28 | $42.23M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $16.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $30.41M 10-Q · filed 2015-08-05 | $30.89M 10-Q · filed 2014-07-31 | $31.52M derived: sum of 3 quarters · filed 2016-02-29 | $37.91M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $13.87M 10-Q · filed 2015-05-05 | $14.29M 10-Q · filed 2014-05-02 | $14.98M derived: sum of 2 quarters · filed 2016-02-29 | $21.37M derived: sum of 3 quarters · filed 2016-02-29 | $27.84M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $7.50M derived: sum of 2 quarters · filed 2016-02-29 | $13.97M derived: sum of 3 quarters · filed 2016-02-29 | $21.10M 10-K · filed 2016-02-29 | $33.91M 10-K · filed 2014-02-26 | |||
| 2013-09-30 | $6.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $12.86M derived: sum of 2 quarters · filed 2014-10-28 | $19.99M 10-Q · filed 2014-10-28 | $27.86M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | $6.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $13.60M 10-Q · filed 2014-07-31 | $21.47M derived: sum of 3 quarters · filed 2015-03-02 | $22.17M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $7.13M 10-Q · filed 2014-05-02 | $15.00M derived: sum of 2 quarters · filed 2015-03-02 | $15.70M derived: sum of 3 quarters · filed 2015-03-02 | $11.76M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $7.87M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $8.57M derived: sum of 2 quarters · filed 2015-03-02 | $4.63M derived: sum of 3 quarters · filed 2015-03-02 | -$1.42M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | -$3.24M derived: sum of 2 quarters · filed 2013-10-28 | -$9.29M 10-Q · filed 2013-10-28 | $5.20M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-06-30 | -$3.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | -$9.99M 10-Q · filed 2013-07-29 | $4.50M derived: sum of 3 quarters · filed 2014-02-26 | $7.83M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2012-03-31 | -$6.05M 10-Q · filed 2013-04-29 | $8.44M derived: sum of 2 quarters · filed 2014-02-26 | $11.77M derived: sum of 3 quarters · filed 2014-02-26 | $14.00M derived: sum of 4 quarters · filed 2014-02-26 | ||||
| 2011-12-31 | $14.49M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $17.82M derived: sum of 2 quarters · filed 2014-02-26 | $20.05M derived: sum of 3 quarters · filed 2014-02-26 | $20.42M 10-K · filed 2014-02-26 | ||||
| 2011-09-30 | $3.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $5.56M derived: sum of 2 quarters · filed 2012-10-29 | $5.93M 10-Q · filed 2012-10-29 | $23.89M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $2.60M 10-Q · filed 2012-08-02 | $20.56M derived: sum of 3 quarters · filed 2013-02-26 | $28.52M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $369.00K 10-Q · filed 2012-04-30 | $18.33M derived: sum of 2 quarters · filed 2013-02-26 | $26.29M derived: sum of 3 quarters · filed 2013-02-26 | $30.31M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | $17.96M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $25.92M derived: sum of 2 quarters · filed 2013-02-26 | $29.94M derived: sum of 3 quarters · filed 2013-02-26 | $31.04M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $7.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $11.98M derived: sum of 2 quarters · filed 2011-10-31 | $13.08M 10-Q · filed 2011-10-31 | $16.30M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | $4.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $5.12M 10-Q · filed 2011-08-01 | $8.34M derived: sum of 3 quarters · filed 2012-02-22 | $10.94M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | $1.10M 10-Q · filed 2011-04-29 | $4.32M derived: sum of 2 quarters · filed 2012-02-22 | $6.92M derived: sum of 3 quarters · filed 2012-02-22 | |||||
| 2009-12-31 | $3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $5.83M derived: sum of 2 quarters · filed 2012-02-22 | $5.50M 10-K · filed 2012-02-22 | |||||
| 2009-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $2.28M 10-Q · filed 2010-10-29 | ||||||
| 2009-06-30 | -$326.00K 10-Q · filed 2010-08-04 | |||||||
| 2008-12-31 | $13.94M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |